When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOK - MyoKardia up 3% on positive mavacamten data
MyoKardia Inc.
MyoKardia (MYOK+3.4%) is up in early trade in response to positive results from an open-label extension study, PIONEER-OLE, evaluating mavacamten in 13 patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) who completed the Phase 2 PIONEER-HCM study. The data will be presented at the American College of Cardiology’s Annual Scientific Session in New Orleans on Sunday, March 17.
More news on: MyoKardia, Healthcare stocks news, Stocks on the move,